Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.018 | 0.7 |
mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.7 |
mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.7 |
mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.7 |
mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | -0.02 | 0.7 |
mRNA | Platin | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |